Stimcell Energetics (STME) Operating Income Growth (1y) (2017 - 2024)
Stimcell Energetics (STME) Operating Income Growth (1y) (2017 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.10 Bn | 176.81 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 108.97 Bn | 99.75 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | 20.97% |
| 6 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn | -18.12% |
| 7 | Dexcom | 28.32 Bn | 27.20 Bn | 750.30 Mn | 90.95% |
| 8 | Smith & Nephew | 26.94 Bn | 26.36 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | 74.18% |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2024 | -80.57% |
| Feb 29, 2024 | 45.41% |
| Nov 30, 2023 | 67.77% |
| Aug 31, 2023 | 64.79% |
| May 31, 2023 | 57.97% |
| Feb 28, 2023 | 6.04% |
| Nov 30, 2022 | 22.57% |
| Aug 31, 2022 | 38.14% |
| May 31, 2022 | 13.89% |
| Feb 28, 2022 | 33.73% |
| Nov 30, 2021 | 6.02% |
| Aug 31, 2021 | -20.36% |
| May 31, 2021 | 27.27% |
| Feb 28, 2021 | 33.14% |
| Nov 30, 2020 | 39.45% |
| Aug 31, 2020 | 18.28% |
| May 31, 2020 | 79.55% |
| Feb 29, 2020 | -252.18% |
| Nov 30, 2019 | -340.02% |
| Aug 31, 2019 | -198.92% |